Publications by authors named "Zorica Trajkova-Antevska"
Article Synopsis
- Detection of minimal residual disease (MRD) during the early treatment phase is crucial for predicting the risk of relapse in children with acute lymphoblastic leukaemia (ALL).
- In a study of 64 patients aged 1-14 with newly diagnosed ALL, MRD was assessed at the end of remission induction therapy using a sensitive flow cytometry method.
- Patients with negative MRD status showed significantly better 5-year event-free survival rates compared to those with positive MRD, indicating that high MRD levels correlate with poorer treatment outcomes.